Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma

Part of paid clinical trials in Bethesda, Maryland.

Sponsor
Henry M. Jackson Foundation for the Advancement of Military Medicine
Study ID
NCT07652580
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
4 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The goal of this observational cohort study is to learn how toxin and occupational exposures, germline genetic variation, and immune dysregulation relate to B-cell non-Hodgkin lymphoma among active-duty service members and other Military Health System beneficiaries. The main questions are whether specific exposures and germline variants are associated with B-cell NHL subtype, immune dysfunction, and clinical outcomes. Participants will complete exposure and medical-history surveys, provide biospecimens for immune and genomic testing, and may be followed annually for up to 3 years.

Key Dates

Start date
May 1, 2025
Status verified
Jun 2026
Primary completion
May 1, 2028
Completion
May 1, 2028

Study Design

Enrollment
300 participants (estimated)

Arms

  • Arm: Cohort 1
    Active duty service members (ADSMs) and other Military Health System (MHS) beneficiaries who have a history of B-cell non-Hodgkin Lymphoma (NHL) and have achieved clinical remission.
  • Arm: Cohort 2
    ADSMs and other MHS beneficiaries ages 18 and older who are newly diagnosed with B-cell NHL and/or are not undergoing active treatment.
  • Arm: Cohort 3
    Other MHS beneficiaries ages 4-17 who are diagnosed with B-cell NHL and are treatment naive.

Primary Outcome Measure

Aim 1: Characterize occupational exposures and their impact on health outcomes and immune health of ADSMs and other MHS beneficiaries with B-cell NHL. [ Time Frame: 3 years ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Uniformed Services University of the Health SciencesBethesdaMaryland20814-
Walter Reed National Military Medical CenterBethesdaMaryland20814
Christin B Destefano
(301) 295-3190
Annika Hamann, RN, BSN, BS
(301) 295-4198
Jeremy Perkins, MD, FACP, COL, US Army (ret) (PRINCIPAL_INVESTIGATOR)
Naval Medical Center PortsmouthPortsmouthVirginia23708-

Find similar trials in Bethesda, MD

Related Studies